IQVIA HOLDINGS INC.
Its government footprint in one place: federal money, influence and market activity, each row linked to its source. Federal figures gathered Oct 25, 2026.
In plain words
2 of its contracts, with $31.2M obligated on them so far, end in the next 18 months and may be competed again. It appears on 42 Senate lobbying filings from 2022 to 2026; 14 of the lobbyists on them once held government posts.
Written by fixed rules from the figures on this page. No opinion, no prediction.
Government moneyⓘ
Obligations: money an agency has formally committed to pay under a contract. Not the same as money already paid, and not revenue.
ⓘ
Obligations: money an agency has formally committed to pay under a contract. Not the same as money already paid, and not revenue.SEC revenue and federal obligations
Not counted: $26.9M in the same 12 months under 2 units carrying the company's name that USAspending lists under another firm. We could not confirm who owns them, so they are left out of the share. See "held back" below.
- FY2026Oct 2025 to Sep 2026-$63K$16.3B year to Dec 31, 2025
- FY2025Oct 2024 to Sep 2025$0$15.4B year to Dec 31, 2024
- FY2024Oct 2023 to Sep 2024$25K$15.0B year to Dec 31, 2023
- FY2023Oct 2022 to Sep 2023$278KRevenue for this year not on file
- FY2022Oct 2021 to Sep 2022-$19KRevenue for this year not on file
What these numbers are
Obligated means an agency committed the money to this company in that period (a signed contract action), as reported to USAspending. It is not a payment and not revenue: a contract can be funded for several years at once, and revenue is booked as the work is done. Some years can exceed revenue for that reason.
Prime contracts only, and only what is published. Work the company does as a subcontractor is not in these figures, and classified contracts are not published on USAspending at all. A low share can mean either. Contract values, ceilings and options are never added in.
Which units count: the USAspending recipient that is the company's SEC registrant; units of the company that USAspending's own records place under it (as parent, or in its family tree); and subsidiaries from the company's SEC Exhibit 21 that carry its name. Joint ventures, units now owned by someone else, and records that only share a name are held back. Both lists are below.
Earlier years count the units the company owns today. A unit we checked by hand (its USAspending parent is out of date) counts from the date the company bought it, or, where no filing gives that date, from the first date a filing shows the company owning it. Other units count for every year shown until their purchase dates are loaded.
Revenue bars are the company's own fiscal year from its 10-K, placed in the federal year it ends in; its fiscal year can end in a different month than the government's.
Fiscal year 2022 onward. Federal fiscal years run October to September; the company's own fiscal year may differ.
Units counted (2), held back (23)
- IQVIA LABORATORIES LLCPAL6MX9M9CJ5 · parent · Exhibit 21 subsidiary carrying the company's name
- IQVIA QUALITY METRIC, INCX3GEBB86SPG7 · parent · Exhibit 21 subsidiary carrying the company's name
Held back: a matching name we could not tie to this company firmly enough. A miss is better than a wrong link.
- MED VANTAGE INC. (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- ORANGE HEALTH SOLUTIONS, INC., (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- OUTCOME SCIENCES, INC. (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- QUALITY HEALTH INC. (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- STI TECHNOLOGIES, INC. (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- IQVIA GOVERNMENT SOLUTIONS INC (USAspending's current parent is HEALTHCARE TECHNOLOGY HOLDINGS INC., not this company)
- PHARMA STRATEGY GROUP LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- SIMPSON HEALTHCARE EXECUTIVES, LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- CT CONSULTING (an old record with no UEI whose name is not exactly the company's SEC name)
- CT CONSULTING INC (an old record with no UEI whose name is not exactly the company's SEC name)
- ENLI HEALTH INTELLIGENCE CORPORATION (an old record with no UEI whose name is not exactly the company's SEC name)
- NEW EXPERIMENTAL THERAPEUTICS OF SAN ANTONIO, LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- QUALITY HEALTH INC. (an old record with no UEI whose name is not exactly the company's SEC name)
- POLARIS SOLUTIONS, LLC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- POLARIS SOLUTIONS, LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- POLARIS SOLUTIONS LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- IQVIA INC. (USAspending's current parent is HEALTHCARE TECHNOLOGY HOLDINGS INC., not this company)
- QUALITY HEALTH (an old record with no UEI whose name is not exactly the company's SEC name)
- AIT BIOSCIENCE, LLC (an old record with no UEI whose name is not exactly the company's SEC name)
- QUALITY HEALTH ,INC (an old record with no UEI whose name is not exactly the company's SEC name)
- POLARIS SOLUTIONS INC (an old record with no UEI whose name is not exactly the company's SEC name)
- PROMETHEUS RESEARCH, LLC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
- EMERALD STAR HOLDINGS, LLC (USAspending's current parent is INSTITUT NEOMED, not this company)
Contracts ending in the next 18 months
- IQVIA pharmacy data$20.9MCenters for Disease Control and Prevention · ends Sep 5, 2027
- Food and Drug Administration · ends Sep 28, 2027
Amount: obligated to date. From the contracts in HillSignal's records tied to this ticker; the full list of contracts ending across government is on Recompetes.
Influence
Revolving door: 14 lobbyists on its filings held government posts
Every post as the lobbyist listed it on the company's Senate LDA filings, one per line.
- Christopher W Eddoweslast filed 2026 · 11 filingsAtlas Crossing LLC
- Senior Policy Advisor, Congressman Lloyd Smucker
- Alexis Oberglast filed 2026 · 11 filingsAtlas Crossing LLC
- Policy Aide, Office of Governor Nathan Deal
- Sean Joycelast filed 2026 · 11 filingsAtlas Crossing LLC
- Chief of Staff, Congressman Patrick McHenry
- Legislative Director, Congressman Shuster
- Communications Director, Congressman Shuster
- Military Legislative Advisor, Congressman Shuster
- Senior Legislative Advisor, Congressman Shuster
- Alex Boltonlast filed 2026 · 6 filingsAtlas Crossing LLC
- Chief of Staff, Rep. Nicole Malliotakis
See all 14Show fewer
- Maren Mcbridelast filed 2026 · 1 filingDla Piper LLP (US)
- Counsel, Rep. Mollohan
- Bobby Cornettlast filed 2026 · 1 filingAtlas Crossing LLC
- Head of Legislative Affairs, Chief Digital and Artificial Intelligence Office, Department of Defense
- Deputy Chief of Staff, Congressman Trent Franks
- Robert Parmiterlast filed 2026 · 1 filingAtlas Crossing LLC
- Chief Counsel/Senior Counsel/Counsel, House Judiciary Subcommittee on Crime, Terrorism, & Homeland Security
- Staff Asst., House Judiciary Committee
- Christopher Kimlast filed 2025 · 5 filingsAtlas Crossing LLC
- Intern, U.S. Rep. Bill Huizenga
- Jennifer Belairlast filed 2025 · 3 filingsAtlas Crossing LLC
- Continued: Rep. Jeb Hensarling
- Parliamentarian-Rep. Pete Sessions
- Legislative Director-Rep. Doug Collins
- Legislative Director/Deputy Parliamentarian/Legislative Clerk/Staff Assistant, House Judiciary Cmte-Rep. Lamar Smith
- Vincent Sarubbi Jrlast filed 2025 · 1 filingDla Piper LLP (US)
- Deputy Chief of Staff and Legislative Director, Rep. Josh Gottheimer
- Legislative Assistant, Sen. Sherrod Brown
- Senior Legislative Assistant, Rep. Donald Norcross
- Legislative Assistant, Rep. Rob Andrews
- Sloane Salzburglast filed 2025 · 1 filingHorizon Government Affairs
- Health Policy Fellowship, Rep. Phil Gingrey
- Christopher Sweetlast filed 2024 · 5 filingsAtlas Crossing LLC
- Deputy Chief of Staff, Legislative Director - Congressman Mario Diaz-Balart
- Timothy Monahanlast filed 2024 · 3 filingsAtlas Crossing LLC
- Sr. Advisor, Rep. Mike Johnson
- Dir. House Operations, Rep. Kevin McCarthy
- Staff/Deputy Staff Dir., Comm. on House Admin
- Prof Staff, House Approps Comm
- Asst Chief Logistics Officer/Special Asst/Project Mgr House CAO
- Dir., CAO IO Operations
- Matthew D. Mikalast filed 2022 · 1 filingAtlas Crossing LLC
- Senior Legislative Assistant, Congressman Tim Walberg
- Legislative Assistant, Congressman Dave Camp
- District Representative, Congressman Nick Smith
Foreign agents (FARA)ⓘ
FARA (Foreign Agents Registration Act): people who work in the US for a foreign government, party or company must register and report what they do and what they are paid.
ⓘ
FARA (Foreign Agents Registration Act): people who work in the US for a foreign government, party or company must register and report what they do and what they are paid.Lobbying firms working for this company also represent these foreign principals. These are separate engagements: the firm's foreign work is not done for this company.
- DLA Piper US LLPlobbied for this company to 2026
- German State of Rheinland-Pfalz · Germanypay not stated in the agreementfiled Sep 25, 2003
Agents registered at this firm, not necessarily assigned to this specific client: Christian Eric Ford, Kalidou Gadio, Mitchell Marder, Michael Fleischman, Harout Samra, Lawrence E. Levinson
Lobbying
42 filings, 2022 to 2026. Paid lobbying firms $2.1M.
Firms: Atlas Crossing LLC, Dla Piper LLP (US), Horizon Government Affairs, Republic Consulting, LLC
Issues: Consumer Issues/Safety/Products, Health Issues, Labor Issues/Antitrust/Workplace, Medical/Disease Research/Clinical Labs, Pharmacy
Contacted: Senate, House Of Representatives, Executive Office Of The President (Eop), Health & Human Services, Dept Of (Hhs), Centers For Medicare And Medicaid Services (Cms), Labor, Dept Of (Dol), Office Of Management & Budget (Omb), White House Office
From the company's Senate LDA filings. Firm fees and in-house spend are reported on different filings, so they are shown apart. Lobbying is legal and common; it shows what the company paid to be heard on, not what it got.
PAC giving
No corporate PAC tied to this company in the FEC records we hold.
Marketⓘ
A 10b5-1 plan is a trading schedule an insider sets up in advance, so sales under it say less about the insider’s view.
ⓘ
A 10b5-1 plan is a trading schedule an insider sets up in advance, so sales under it say less about the insider’s view.Members of Congress who traded it
- Kevin Hern OKSold $1,001 - $15,000; Sold $15,001 - $50,000; Sold $1,001 - $15,000filed 2026-09-28
- Kevin Hern R-OKSold $50,001 - $100,000filed 2026-04-03
- Rohit Khanna D-CASold $1,001 - $15,000filed 2025-10-03
- Rob Bresnahan R-PASold $1,001 - $15,000filed 2025-05-31
- Rob Bresnahan R-PASold $1,001 - $15,000filed 2025-03-27
- Rohit Khanna D-CABought $1,001 - $15,000filed 2025-03-06
- Rohit Khanna D-CABought $1,000,001 - $5,000,000filed 2025-01-08
- Rohit Khanna D-CASold $1,001 - $15,000filed 2024-01-04
Fund holders with contract wins (13F)ⓘ
13F: a quarterly SEC filing in which large investment managers list the US stocks they hold, filed up to 45 days after the quarter.
ⓘ
13F: a quarterly SEC filing in which large investment managers list the US stocks they hold, filed up to 45 days after the quarter.None found.
People and connections
Key people
- Berkshire James GSee Remarks
Connections
Connections to other companies, executives and members of Congress, from disclosed trades, shared officers and public filings, are part of Pro. See Pro
Activity
Every record that names this company by ticker, newest first: awards, bills, executive actions, SEC filings, news, private raises and patents.
- NewsAppaloosa Management Sold Entire Stake In American Airlines Group; ASML Holding; Delta Air Lines; Deutsche Bank; Goodyear Tire & Rubber Company; IQVIA Holdings; Mohawk Industries; Owens Corning; Taiwan Semiconductor Manufacturing Company; United Airlines Holdings.May 15, 2026
- NewsWill IQVIA's (IQV) AI‑Driven Biosimilar Partnership with Kexing Reshape Its Long‑Term Narrative?May 15, 2026
- NewsIQVIA’s Q1 Earnings Call: Our Top 5 Analyst QuestionsMay 15, 2026
- NewsThe Broyhill Q1 2026 Portfolio Strategy And PositioningMay 15, 2026
- NewsVeeva Systems Expands AI and Vault CRM Momentum: Time to Buy or Hold?May 14, 2026
- NewsIQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled CapabilitiesMay 13, 2026
- NewsIQVIA Holdings Inc. (IQV) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026
- NewsIQVIA Advances Strategic Collaboration With Kexing Biopharm To Support Global, Multi-Product Biosimilar Development And Commercialization ProgramMay 13, 2026
- BillClinical Trial Modernization ActApr 29, 2026
- AwardTHE LEWIN GROUP, INC.: $11.3M Department of Health and Human Services ContractApr 23, 2026
- AwardOAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATED: $16.6M Department of Health and Human Services ContractApr 17, 2026
- AwardTRIWEST HEALTHCARE ALLIANCE CORP: $28.3M Department of Veterans Affairs ContractMar 1, 2026
- BillTo amend section 495 of the Public Health Service Act to require inspections of foreign laboratories conducting biomedical and behavioral research to ensure compliance with applicable animal welfare requirements, and for other purposes.Jan 20, 2026
- BillCARGO Act of 2025May 19, 2025
Sources and limits
USAspending (prime contracts only; no subcontracts or classified work; defense contracts can arrive up to 90 days after signing), SEC EDGAR, Senate LDA, FEC, House and Senate disclosures, the Federal Register and the White House. Companies are tied to records by exact name, a verified alias or a subsidiary in the company's own Exhibit 21; a miss is better than a wrong link. A shared date is not proof of cause, and nothing here is investment advice.